Schizophrenia
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
TREMOR, HEREDITARY ESSENTIAL, 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Delusions
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hallucinations
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Negativism
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Static Tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tremor of hands
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Social and occupational deterioration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Mental Depression
|
0.370 |
Biomarker
|
disease |
PSYGENET |
Depression and psychotic symptoms that occur in a large proportion of AD patients have been associated with monoamine genes coding for metabolic enzymes (COMT), transporters (5-HTTLPR) and receptors (DRD1; DRD3).
|
17851196 |
2007 |
Mental Depression
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Depression and psychotic symptoms that occur in a large proportion of AD patients have been associated with monoamine genes coding for metabolic enzymes (COMT), transporters (5-HTTLPR) and receptors (DRD1; DRD3).
|
17851196 |
2007 |
Depressive disorder
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Depression and psychotic symptoms that occur in a large proportion of AD patients have been associated with monoamine genes coding for metabolic enzymes (COMT), transporters (5-HTTLPR) and receptors (DRD1; DRD3).
|
17851196 |
2007 |
Depressive disorder
|
0.360 |
Biomarker
|
disease |
PSYGENET |
Depression and psychotic symptoms that occur in a large proportion of AD patients have been associated with monoamine genes coding for metabolic enzymes (COMT), transporters (5-HTTLPR) and receptors (DRD1; DRD3).
|
17851196 |
2007 |
Depressed mood
|
0.060 |
GeneticVariation
|
phenotype |
BEFREE |
Depression and psychotic symptoms that occur in a large proportion of AD patients have been associated with monoamine genes coding for metabolic enzymes (COMT), transporters (5-HTTLPR) and receptors (DRD1; DRD3).
|
17851196 |
2007 |
Tardive Dyskinesia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
|
19439249 |
2009 |
Drug-induced tardive dyskinesia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
|
19439249 |
2009 |
Abnormal involuntary movement
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
DRD3 genotype and age at first antipsychotic treatment contributed significantly to total score on the Abnormal Involuntary Movements Scale (AIMS).
|
10395214 |
1999 |
Abnormal behavior
|
0.050 |
GeneticVariation
|
phenotype |
BEFREE |
Dopamine D3 receptor gene (DRD3) variants have been implicated in the pathogenesis of psychiatric disorders.
|
10490702 |
1999 |
Mental disorders
|
0.040 |
GeneticVariation
|
group |
BEFREE |
Dopamine D3 receptor gene (DRD3) variants have been implicated in the pathogenesis of psychiatric disorders.
|
10490702 |
1999 |
Diagnosis, Psychiatric
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
DRD3 variants were not associated with these symptomatologic factors, and consideration of possible stratification effects, such as sex and psychiatric diagnosis, did not reveal any association either.
|
10490702 |
1999 |
Kidney Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Dopamine D3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients.
|
15004255 |
2004 |
Chronic schizophrenia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder.
|
18320559 |
2008 |
Mild dementia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type.
|
19363270 |
2009 |
Widespread Chronic Pain
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls.
|
19464960 |
2009 |
Migraine Disorders
|
0.030 |
GeneticVariation
|
group |
BEFREE |
DRD3 genotype and allelic variants were not related to the risk for migraine in Caucasian Spanish people.
|
20236178 |
2010 |